| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |